Accession Number: | 0001437749-22-014039 |
Date: | 2022-05-31 |
Issuer: | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) |
Original Submission Date: |
BHALLA AMIT
4995 BRADENTON AVE., SUITE 240
DUBLIN, OH 43017
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-05-31 | A | 2,500 | a | $0.00 | 58,068 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | stock issued under the amended and restated 2014 stock incentive plan in partial payment of monthly non-employee director fees. |
f2 | issuance deferred at the request of the reporting person. |